| Literature DB >> 23718565 |
Carola M E Döpp, Maud J L Graff, Steven Teerenstra, Maria W G Nijhuis-van der Sanden, Marcel G M Olde Rikkert, Myrra J F J Vernooij-Dassen.
Abstract
BACKGROUND: To evaluate the effectiveness of a multifaceted implementation strategy on physicians' referral rate to and knowledge on the community occupational therapy in dementia program (COTiD program).Entities:
Mesh:
Year: 2013 PMID: 23718565 PMCID: PMC3671244 DOI: 10.1186/1471-2296-14-70
Source DB: PubMed Journal: BMC Fam Pract ISSN: 1471-2296 Impact factor: 2.497
Figure 1Flow of participants through the trial. OT = occupational therapist; MD = physician.
Baseline characteristics of participating physicians and occupational therapists
| Type of physician, N (%) | | | | | 0,92 |
| General practitioner | 11 (30,6%) | | 13 (29,5%) | | |
| Medical specialist | 25 (69,4%) | | 31 (70,5%) | | |
| Age, mean (SD) | 49,7 (7,5) | (n = 29) | 48,6 (8,0) | (n = 38) | 0,60 |
| Range | 36-63 | | 26-61 | | |
| Women, N (%) | 17 (47,2%) | | 17 (38,6%) | | 0,44 |
| Active as MD (years), mean (SD) | 22,0 (7,1) | (n = 27) | 20,74 (7,1) | (n = 35) | 0,50 |
| Range | 10-34 | | 6-35 | | |
| Experience dementia (years), mean (SD) | 17,1 (6,6) | (n = 27) | 17,2 (7,1) | (n = 33) | 0,98 |
| Range | 5-30 | | 5-31 | | |
| Specialization in Geriatrics, N (%) | 17 (53,1%) | (n = 32) | 24 (58,5%) | (n = 41) | 0,64 |
| Specialized (years), mean (SD) | 11,8 (7,4) | (n = 15) | 11,6 (7,7) | (n = 24) | 0,94 |
| Range | 3-24 | | 1-26 | | |
| | | | | | |
| Age (years), mean (SD) | 38,5 (10,7) | | 35,8 (9,9) | | 0,23 |
| Range | 22 – 58 | (n = 36) | 22 – 57 | (n = 54) | |
| Women, N (%) | 36 (100%) | | 54 (93,1%) | | 0,11 |
| Qualified (years), mean (SD) | 13,7 (8,9) | (n = 34) | 13,4 (10,1) | (n = 44) | 0,90 |
| Active as OT (years), mean (SD) | 13,7 (8,5) | (n = 35) | 13,2 (9,4) | (n = 44) | 0,96 |
| Post-graduate completed (months), mean (SD) | 13,0 (21,8) | | 13,7 (23,1) | | 0,90 |
| Range | 1 – 120 | (n = 34) | 1 – 101 | (n = 43) | |
| Experience dementia (years), mean (SD) | 7,5 (6,2) | (n = 35) | 7,8 (7,1) | (n = 43) | 0,81 |
| Cases according to COTiD*, N (%) | | | | | 0,25 |
| 0 | 8 (22,9%) | | 12 (27,3%) | | |
| 1-5 | 21 (60%) | | 29 (65,9%) | | |
| 6-10 | 3 (8,6%) | | 3 (6,8%) | | |
| 11-15 | 3 (8,6%) | | 0 (0%) | | |
| 16-20 | 0 (0%) | | 0 (0%) | | |
| More than 20 | 0 (0%) | 0 (0%) | |||
Mean scores and group differences regarding physicians’ knowledge on the COTiD program
| | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 – Eligibility of clients | 0-8 | 5,65 (1,12) | 5,92 (1,08) | −0,36 | 5,75 (1,21) | 5,48 (1,33) | 0,27 | 5,82 (1,43) | 5,67 (1,33) | 0,15 |
| 2 - Effect on client | 0-9 | 4,35 (2,09) | 4,52 (1,78) | −0,17 | 4,21 (2,04) | 5,00 (1,29) | −0,79 | 4,65 (1,80) | 4,96 (1,63) | −0,31 |
| 3 – Effect on caregiver | 0-9 | 4,24 (1,95) | 5,28 (2,05) | −1,04 | 4,50 (2,06) | 5,48 (1,16) | 0,98 | 5,18 (1,47) | 5,56 (1,16) | −0,38 |
| 4 - General content | 0-4 | 2,53 (0,87) | 3,08 (0,86) | −0,55 | 0,0 (0,0) | 0,0 (0,0) | 0 | 3,18 (0,39) | 2,89 (1,22) | 0,29 |
| 5 - Pharmacological vs. non-pharmacological | 0-4 | 2,24 (1,09) | 2,00 (1,12) | 0,24 | 1,89 (1,10) | 2,12 (1,20) | −0,23 | 1,47 (1,07) | 1,59 (0,84) | −0,12 |
| 6 – Facilitation | 0-3 | 2,06 (0,90) | 2,36 (0,70) | −0,3 | 1,86 (0,89) | 1,96 (0,84) | −0,1 | 1,88 (0,93) | 2,19 (0,96) | −0,31 |
| 7 – Cost-effect | 0-3 | 0,0 (0,0) | 0,04 (0,20) | −0,04 | 0,14 (0,36) | 0,04 (0,20) | 0,1 | 0,06 (0,24) | 0,11 (0,32) | −0,05 |
| 8 – Reimbursement | 0-5 | 3,88 (1,45) | 3,54 (1,33) | 0,34 | 4,39 (0,96) | 3,08 (1,75) | 1,31 | 4,12 (1,65) | 3,63 (1,64) | 0,49 |
Results of the multivariate analyses regarding the difference in physicians’ knowledge per question
| | ||||
|---|---|---|---|---|
| 1 - Eligibility of clients | 0,35 | −0,37 to 1,08 | 0,40 | −0,38 to 1,18 |
| 2 - Effect on client | −0,37 | −1,25 to 0,52 | −0,01 | −0,98 to 0,97 |
| 3 - Effect on caregiver | −0,53 | −1,69 to 0,63 | −0,22 | −1,09 to 0,65 |
| 4 - General content | −0,12 | −1,42 to 1,18 | −0,01 | −1,01 to 0,98 |
| 5 - Pharmacological vs. non-pharmacological | −0,27 | −0,79 to 0,26 | −0,11 | −0,64 to 0,42 |
| 6 - Facilitation | 0,03 | −0,42 to 0,48 | −0,08 | −0,53 to 0,37 |
| 7 - Cost-effect | 0,05 | −0,12 to 0,22 | −0,01 | −0,19 to 0,17 |
| 8 - Reimbursement | 0,77 | −0,21 to 1,75 | 0,10 | −0,87 to 1,08 |
Exposure of physicians in the experimental group to the multifaceted implementation strategy
| 1,1 (0,93) | | 40 | 0 | |
| 0 times, N (%) | 13 | 32,5% | | |
| 1 time, N (%) | 12 | 30% | | |
| 2 times, N (%) | 13 | 32,5% | | |
| 3 times, N (%) | 2 | 5% | | |
| 10,23 (9,17) | | 40 | 0 | |
| M (SD) | | | | |
| 12 | 60% | 20 | 20 | |
| N (%) | | | | |
| 23 | 92% | 25 | 15 | |
| N (%) | | | | |
| 6 | 15% | 40 | 0 | |
| N (%) |